Presentation JIM 2020 Ultra LOW LDL is the target for high risk patients Presenter: Francesco Prati February 13, 2020 REGISTER for free or LOG IN to view this content Coronary CAD Pharma Presentation JIM 2020 LDL-cholesterol Up Next Presentation JIM 2020 Optimal LDL levels in patients with ACS undergoing PCI Presenter: Giuseppe Musumeci February 13, 2020 More slides + Presentation JIM 2020 Long-term antithrombotic therapy in high-risk PCI patients Presenter: Alberto Menozzi February 13, 2020 Presentation JIM 2020 Long term antithrombotic therapy in high risk PCI: Consider low-dose rivaroxaban with SAPT Presenter: Giuseppe Tarantini February 13, 2020 We Recommend
Presentation JIM 2020 Optimal LDL levels in patients with ACS undergoing PCI Presenter: Giuseppe Musumeci February 13, 2020
Presentation JIM 2020 Long-term antithrombotic therapy in high-risk PCI patients Presenter: Alberto Menozzi February 13, 2020
Presentation JIM 2020 Long term antithrombotic therapy in high risk PCI: Consider low-dose rivaroxaban with SAPT Presenter: Giuseppe Tarantini February 13, 2020